I

Imvax, Inc.

44 employees

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Glioblastoma Multiforme
Immunotherapy
Therapeutics
Research
Pharmaceutical
Autologous vaccines
Biopharmaceuticals
Clinical Trials

Date founded

2015

Funding rounds raised

Total raised

$112M

from 5 investors over 5 rounds

I

Imvax, Inc. raised $112M on July 16, 2020

Investors: The Invus Group, Magnetar Capital and TLPInvest™

I

Imvax, Inc. raised $40M on September 10, 2019

Investors: WILD Group Management AG and Magnetar Capital

FAQ